2m 2m 2m 2m 2m 2m 2m
SS INNOVATIONS (SSII)
NASDAQ
$3.35-$0.05 (-1.35%)
Price as of Jun 23, 2026 7:58 PM EDT- $672.4MMarket Cap
- -40.53%1-Year Change
- Medical DevicesIndustry
SS INNOVATIONS (SSII)
$3.35-$0.05 (-1.35%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 38.4M +97.11% | 19.5M +231.18% | 5.9M N/A | N/A N/A | |
Cost of Revenue | 22.9M +88.08% | 12.2M +136.85% | 5.1M N/A | N/A N/A | |
Gross Profit | 19.5M +131.23% | 8.5M +1,065.00% | 725,528 N/A | 0 N/A | |
Sales and Marketing Expense | 14.8M +46.18% | 10.2M +0.93% | 10.1M N/A | N/A N/A | |
Research and Development Expense | -3.7M +47.92% | -2.5M +135.37% | -1.1M +1,351.03% | -72,959 +7,195.90% | |
Depreciation and Amortization Expense | 1.1M +146.76% | 436,005 +185.46% | 152,738 +1,570.55% | 9,143 -51.33% | |
Total Operating Expenses | 27.7M +1.13% | 27.4M +30.61% | 21.0M +757.96% | 2.4M +73.95% | |
Operating Profit | -8.2M -56.82% | -19.0M -6.40% | -20.3M +816.13% | -2.2M +49.09% | |
Interest Income | 1.1M +43.07% | 798,000 N/A | N/A N/A | 279,975 +461.76% | |
Interest Expense | -271,633 -14.37% | -317,234 -47.50% | -604,308 +1,227.30% | -45,529 +4,199.24% | |
Interest Income and Expense and Net | 870,091 +80.98% | 480,766 +179.56% | -604,308 -357.76% | 234,446 +398.84% | |
Total Nonoperating Income and Expense | 33,087 +118.88% | -175,235 -71.00% | -604,308 -357.60% | 234,594 +403.59% | |
Income before Taxes | -8.2M -57.39% | -19.2M -8.27% | -20.9M +843.43% | -2.2M +49.09% | |
Income Taxes | 4.0M N/A | N/A N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -12.1M -36.68% | -19.2M -8.27% | -20.9M +843.43% | -2.2M +49.09% | |
Net Income from Continuing Operations Applicable to Common | -8.2M -57.39% | -19.2M -8.27% | -20.9M +843.43% | -2.2M +49.09% | |
Basic EPS and Net Income | -0.06 -45.45% | -0.11 -21.43% | -0.14 +180.00% | -0.05 0.00% | |
Diluted EPS and Net Income | -0.06 -45.45% | -0.11 -21.43% | -0.14 +180.00% | -0.05 0.00% | |
Basic Weighted Average Shares | 190.0M +11.22% | 170.8M +17.93% | 144.9M +254.38% | 40.9M +43.53% | |
Diluted Weighted Average Shares | 198.7M +9.66% | 181.2M +19.16% | 152.1M +272.00% | 40.9M +43.53% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.2M +587.33% | 466,500 -76.93% | 2.0M +49.65% | 1.4M +233.03% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.2M +587.33% | 466,500 -76.93% | 2.0M +49.65% | 1.4M +233.03% | |
Total Current Assets | 48.8M +78.00% | 27.4M +27.94% | 21.4M +391.48% | 4.4M +968.47% | |
Accumulated Depreciation | 1.5M +139.50% | 645,487 +94.52% | 331,841 +280.58% | 87,193 +11.71% | |
Property and Plant and Equipment and Net | 9.1M +68.97% | 5.4M +662.45% | 706,405 +6,097.08% | 11,399 -44.51% | |
Total Long-Term Assets | 9.1M -39.20% | 15.0M +48.39% | 10.1M +88,393.16% | 11,399 -44.51% | |
Total Assets | 74.2M +75.12% | 42.4M +34.49% | 31.5M +620.95% | 4.4M +919.92% | |
Income Taxes Payable | 5.3M +6,440.57% | 80,833 -10.60% | 90,415 N/A | N/A N/A | |
Total Short-Term Debt | 19.0M +154.77% | 7.5M +196.79% | 2.5M -37.25% | 4.0M +2,658.62% | |
Total Current Liabilities | 26.2M +23.03% | 21.3M +151.72% | 8.5M +109.16% | 4.1M +1,310.20% | |
Total Long-Term Debt | 188,622 +152.11% | 74,817 -85.34% | 510,189 N/A | N/A N/A | |
Total Long-Term Liabilities | 288,764 -96.20% | 7.6M +128.56% | 3.3M N/A | N/A N/A | |
Total Liabilities | 36.0M +24.47% | 28.9M +145.20% | 11.8M +191.22% | 4.1M +1,310.20% | |
Retained Earnings | -55.8M +27.78% | -43.7M +78.13% | -24.5M +129.27% | -10.7M +26.10% | |
Total Stockholders Equity | 38.2M +184.00% | 13.5M -31.75% | 19.7M +6,057.80% | 320,213 +126.58% | |
Total Shares Outstanding | 194.2M +13.16% | 171.6M +0.51% | 170.7M +216.79% | 53.9M +42.38% | |
Cash Flow | |||||
Cash from Operating Activities | -18.5M +95.13% | -9.5M -38.18% | -15.4M +970.52% | -1.4M +295.51% | |
Capital Expenditures | 3.7M +453.16% | 661,479 -76.06% | 2.8M N/A | N/A N/A | |
Cash from Investing Activities | -3.7M +453.16% | -661,479 +48.96% | -444,077 -85.20% | -3.0M -7,963.70% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 26.2M +177.60% | 9.4M -58.65% | 22.8M +323.61% | 5.4M +844.20% | |
Financials Ratio | |||||
Gross Margin | 40.19% +7.69% | 37.31% +202.17% | 12.35% N/A | N/A N/A | |
Operating Margin | -21.36% -78.09% | -97.52% -71.74% | -345.07% N/A | N/A N/A | |
Return on Assets | -20.80% -59.87% | -51.83% -55.46% | -116.35% +26.19% | -92.21% -76.81% | |
Return on Equity | -46.94% -59.35% | -115.45% -44.60% | -208.38% -78.27% | -958.97% -335.08% | |
Revenue Growth | 97.11% -57.99% | 231.18% N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.86 +44.69% | 1.29 -49.17% | 2.53 +134.97% | 1.08 -24.23% | |
Cash Ratio | 0.12 +457.99% | 0.02 -90.83% | 0.24 -28.45% | 0.33 -76.38% | |
Debt-to-Equity Ratio | 0.50 -10.30% | 0.56 +265.01% | 0.15 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.26 +45.46% | 0.18 +85.28% | 0.10 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow